Literature DB >> 33090307

Hypericum perforatum L.: a medicinal plant with potential as a curative agent against obesity-associated complications.

Hilal Büşra Tokgöz1, Filiz Altan2.   

Abstract

Obesity is a low-grade inflammatory disease that is getting increasingly common among adults and children and causes different complications. Insulin resistance, Type II diabetes, atherosclerosis, metabolic syndrome and hypertension are among the major health problems, that are associated with obesity. Some medications are used to treat obese individuals and metabolic surgery is recommended, if appropriate, for individuals with a BMI ≥ 40. Due to the fact that medications and metabolic surgery are not tolerated by all, researchers focus on alternative therapies. Medicinal plants comprise the most important group of these alternative treatments. Hypericum perforatum L. is the medicinal plant, which we focused on in this study. Hypericum perforatum L. has been recognized as a medicinally valuable plant for over 2000 years. It has been used for generations to treat anxiety, depression, insomnia, gastritis, hemorrhoids, wounds, and burns. Recent studies have indeed shown promising effects for the treatment of obesity. In this study, 3T3-L1 adipocytes were used to mimic the adipocyte differentiation associated with obesity in cellular terms. Lipoprotein lipase (Lpl), Diacylglycerol-O-acyltransferase 1 (Dgat1), Fatty acid synthase (Fasn) markers were used to study the lipid accumulation, and Collagen V (ColV) was used to study cell elasticity to investigate the relationship of the effects of the administration of Hypericum perforatum L. with obesity.

Entities:  

Keywords:  Hypericum perforatum L.; Inflammation; Insulin resistance; Medicinal plants; Obesity

Mesh:

Substances:

Year:  2020        PMID: 33090307     DOI: 10.1007/s11033-020-05912-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  23 in total

Review 1.  Neonatal programming of innate immune function.

Authors:  S J Spencer; M A Galic; Q J Pittman
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-11-02       Impact factor: 4.310

2.  Anti-Obesity Effects of Aster spathulifolius Extract in High-Fat Diet-Induced Obese Rats.

Authors:  Sa-Jic Kim; Chae-Young Bang; Yuan-Ri Guo; Se-Young Choung
Journal:  J Med Food       Date:  2016-02-23       Impact factor: 2.786

Review 3.  Mechanisms of insulin resistance in obesity.

Authors:  Jianping Ye
Journal:  Front Med       Date:  2013-03-09       Impact factor: 4.592

4.  DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes.

Authors:  Charles A Harris; Joel T Haas; Ryan S Streeper; Scot J Stone; Manju Kumari; Kui Yang; Xianlin Han; Nicholas Brownell; Richard W Gross; Rudolf Zechner; Robert V Farese
Journal:  J Lipid Res       Date:  2011-02-11       Impact factor: 5.922

5.  Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity.

Authors:  C N Sadur; T J Yost; R H Eckel
Journal:  J Clin Endocrinol Metab       Date:  1984-12       Impact factor: 5.958

6.  Obesity-related overexpression of fatty-acid synthase gene in adipose tissue involves sterol regulatory element-binding protein transcription factors.

Authors:  M Boizard; X Le Liepvre; P Lemarchand; F Foufelle; P Ferré; I Dugail
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

Review 7.  Lipoprotein lipase: from gene to obesity.

Authors:  Hong Wang; Robert H Eckel
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-03-24       Impact factor: 4.310

Review 8.  Association of sleep disturbances with obesity, insulin resistance and the metabolic syndrome.

Authors:  Dorit Koren; Elsie M Taveras
Journal:  Metabolism       Date:  2018-04-06       Impact factor: 8.694

9.  In vivo regulation of adipose tissue lipoprotein lipase in normal rats made hyperinsulinemic and in hyperinsulinemic genetically-obese (fa/fa) rats.

Authors:  J Terrettaz; I Cusin; J Etienne; B Jeanrenaud
Journal:  Int J Obes Relat Metab Disord       Date:  1994-01

Review 10.  Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis.

Authors:  Chi-Liang Eric Yen; Scot J Stone; Suneil Koliwad; Charles Harris; Robert V Farese
Journal:  J Lipid Res       Date:  2008-08-29       Impact factor: 5.922

View more
  2 in total

Review 1.  St. John's wort (Hypericum perforatum) and depression: what happens to the neurotransmitter systems?

Authors:  Gita Kholghi; Shirin Arjmandi-Rad; Mohammad-Reza Zarrindast; Salar Vaseghi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-03-16       Impact factor: 3.000

Review 2.  Hypericum perforatum: Traditional uses, clinical trials, and drug interactions.

Authors:  Seyedeh Zahra Nobakht; Maryam Akaberi; Amir Hooshang Mohammadpour; Ali Tafazoli Moghadam; Seyed Ahmad Emami
Journal:  Iran J Basic Med Sci       Date:  2022-09       Impact factor: 2.532

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.